GeoVax Labs, Inc. (GOVX)
0.206
-0.01
(-3.15%)
USD |
NASDAQ |
Oct 23, 16:00
0.2035
0.00 (0.00%)
After-Hours: 20:00
GeoVax Labs Market Cap : 1.518M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.518M |
| October 22, 2026 | 1.567M |
| October 21, 2026 | 1.711M |
| October 20, 2026 | 1.674M |
| October 19, 2026 | 1.676M |
| October 16, 2026 | 1.756M |
| October 15, 2026 | 1.900M |
| October 14, 2026 | 1.778M |
| October 13, 2026 | 1.957M |
| October 12, 2026 | 2.080M |
| October 09, 2026 | 2.071M |
| October 08, 2026 | 2.112M |
| October 07, 2026 | 2.133M |
| October 06, 2026 | 2.126M |
| October 05, 2026 | 2.357M |
| October 02, 2026 | 2.359M |
| October 01, 2026 | 2.374M |
| September 30, 2026 | 2.462M |
| September 29, 2026 | 2.594M |
| September 28, 2026 | 2.548M |
| September 25, 2026 | 2.587M |
| September 24, 2026 | 2.655M |
| September 23, 2026 | 2.786M |
| September 22, 2026 | 2.677M |
| September 21, 2026 | 2.643M |
| Date | Value |
|---|---|
| September 18, 2026 | 2.630M |
| September 17, 2026 | 2.822M |
| September 16, 2026 | 2.986M |
| September 15, 2026 | 3.084M |
| September 14, 2026 | 3.170M |
| September 11, 2026 | 3.412M |
| September 10, 2026 | 3.430M |
| September 09, 2026 | 3.455M |
| September 08, 2026 | 3.449M |
| September 04, 2026 | 3.560M |
| September 03, 2026 | 3.735M |
| September 02, 2026 | 4.072M |
| September 01, 2026 | 4.463M |
| August 31, 2026 | 4.660M |
| August 28, 2026 | 5.313M |
| August 27, 2026 | 5.284M |
| August 26, 2026 | 4.643M |
| August 25, 2026 | 4.730M |
| August 24, 2026 | 5.058M |
| August 21, 2026 | 4.758M |
| August 20, 2026 | 4.436M |
| August 19, 2026 | 4.382M |
| August 18, 2026 | 4.794M |
| August 17, 2026 | 4.827M |
| August 14, 2026 | 5.291M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
| Imunon, Inc. | 5.762M |
Market Cap Related Metrics
| Price to Book Value | 0.8622 |
| Price | 0.206 |
| Earnings Yield | -6.76K% |